Somatostatin effects on lower esophageal sphincter function.
The effect of somatostatin (GH-RIH) infusion (2 microgram/min) on lower esophageal sphincter pressure (LESP) responses to various stimuli was evaluated in adult male baboons. GH-RIH infusion did not affect basal LESP, but did cause a significant suppression of mean immunoreactive insulin (IRI) to 5.8% of basal values (P less than 0.05). Pentagastrin IV caused dose-related increases in LESP that were unaffected by GH-RIH. Abdominal compression caused a threefold rise in LESP (P less than 0.005) both without and with GH-RIH. However, atropine (20 microgram/kg iv bolus) completely blocked this cholinergic LES pressure response. Intragastric alkali as well as intragastric glycine caused significant increases in LESP (P less than 0.05). These LESP responses to alkali and to glycine were totally abolished by GH-RIH. In conclusion, GH-RIH infusion in the baboon does not affect basal LESP, LES smooth muscle response to exogenous stimulation, nor a cholinergically mediated LES response. GH-RIH does inhibit the response of LESP both to intragastric alkali and to glycine by the apparent suppression of a hormonally mediated mechanism.
D000468:Alkalies; D000818:Animals; D001285:Atropine; D004943:Esophagogastric Junction / Q000187:drug effects*; D005998:Glycine; D000882:Haplorhini; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D010215:Papio; D013004:Somatostatin / Q000494:pharmacology*
D000468:Alkalies; D013004:Somatostatin; D001285:Atropine; D005998:Glycine